Behavioral health technology company Rethink First is reportedly being prepped for sale and could fetch a price as high as $1.5 billion, Behavioral Health Business reports. Axios initially reported the news.
K1 Investment Management – which holds a strategic investment in the autism care tech company – is looking for a buyer and the process is being led by Morgan Stanley.
Founded in 2007, New York-based Rethink serves public and private health providers with data collection related to applied behavior analysis therapy, along with offering video-based training for staff and appointment management software. Rethink also provides software management for school districts nationwide. Read more.
